Tag

AstraZeneca

AstraZeneca research

Enhertu approved in the EU for the treatment of HER2-positive metastatic breast cancer

January 21, 2021

AstraZeneca and Daiichi Sankyo have …

AstraZeneca scientist

AstraZeneca’s Imfinzi approved in the EU

January 19, 2021

AstraZeneca’s Imfinzi (durvalumab) has been …

David Fredrickson

AstraZeneca’s Enhertu approved in the US

January 18, 2021

AstraZeneca and Daiichi Sankyo’s Enhertu …

Carlos de Sousa

Ultimovacs announces Phase II collaboration study in ovarian cancer

January 12, 2021

Ultimovacs will participate in the …

Mene Pangalos

AstraZeneca’s Farxiga granted Priority Review in the US

January 12, 2021

AstraZeneca’s Farxiga (dapagliflozin) has been granted Priority …

AstraZeneca scientist

AstraZeneca’s COVID-19 vaccine obtains emergency use authorization in India

January 7, 2021

AstraZeneca’s COVID-19 vaccine has been …

Pascal Soriot

AstraZeneca’s COVID-19 vaccine authorised for emergency supply in the UK

January 4, 2021

The UK Medicines and Healthcare …

AstraZeneca RD

AstraZeneca to acquire Alexion in USD 39 billion deal

December 14, 2020

AstraZeneca and Alexion Pharmaceuticals have …

AstraZeneca Cambridge

Interim analysis results from AstraZeneca-Oxford Phase III trials

December 9, 2020

Results of an interim analysis …

José Baselga

AstraZeneca announces results from Calquence trial

December 7, 2020

Long-term follow-up results from the …

Mene Pangalos

AstraZeneca’s Forxiga approved in Japan for chronic heart failure

December 2, 2020

Forxiga (dapagliflozin) has been approved …

Ruud Dobber

AstraZeneca divests Crestor to Grünenthal in Europe

December 1, 2020

AstraZeneca has agreed to sell …

David Fredrickson

Imfinzi approved in the US for less-frequent, fixed-dose use

November 24, 2020

AstraZeneca’s Imfinzi (durvalumab) has been approved in …

AstraZeneca research

Calquence approved in the EU for the treatment of chronic lymphocytic leukaemia

November 9, 2020

AstraZeneca’s Calquence (acalabrutinib), a selective …

David Fredrickson

AstraZeneca’s Lynparza approved in the EU in ovarian cancer

November 6, 2020

AstraZeneca and MSD’s Lynparza (olaparib) has been …

AstraZeneca BioVentureHub

Waters establishes a team in BioVentureHub

November 2, 2020

Waters Corporation has established a …

1
2
3
···
19